Pediatrx Inc Share Price OTC Bulletin Board
Equities
US70532X1072
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
05-07 | IMAC Holdings, Inc. acquired Assets of Theralink Technologies, Inc. | CI |
05-06 | Theralink Technologies, Inc. cancelled the acquisition of IMAC Holdings, Inc. in a reverse merger transaction. | CI |
Sales 2022 | 0.57 43.85 | Sales 2023 | 0.61 46.85 | Capitalization | 5.54M 427M |
---|---|---|---|---|---|
Net income 2022 | -12M -926M | Net income 2023 | -30M -2.32B | EV / Sales 2022 | 44,915,754 x |
Net Debt 2022 | 3.98M 307M | Net Debt 2023 | 18.76M 1.45B | EV / Sales 2023 | 40,045,900 x |
P/E ratio 2022 |
-1.59
x | P/E ratio 2023 |
-0.18
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 17.39% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 43 | 31/12/08 | |
Michael Ruxin
CTO | Chief Tech/Sci/R&D Officer | 78 | 31/12/17 |
Trevor McCartney
IRO | Public Communications Contact | - | 28/02/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Busch
CHM | Chairman | 66 | 17/06/20 |
Michael Ruxin
CTO | Chief Tech/Sci/R&D Officer | 78 | 31/12/17 |
Director of Finance/CFO | 43 | 31/12/08 |
1st Jan change | Capi. | |
---|---|---|
+20.44% | 127B | |
+24.17% | 117B | |
+25.44% | 27.67B | |
-18.63% | 20.33B | |
-15.17% | 16.79B | |
-16.15% | 15.63B | |
+12.73% | 14.84B | |
-47.10% | 14.65B | |
+56.97% | 14.43B |